About SelectMDx:
SelectMDx is for patients who have an abnormal PSA and/or DRE who are being considered for a prostate biopsy.
Unlike PSA, which is a measurement that is specific to the prostate but not necessarily prostate cancer, SelectMDx has been shown in research to more accurately assess an individual's risk of having prostate cancer, and more specifically, clinically significant prostate cancer (greater than or equal to Gleason 7).
This is done by simply collecting a sample of urine after a digital rectal examination (physical examination of ones prostate by their health care provider).
Patient Resources:
Below are several resources designed to help patients and their family better understand how SelectMDx is used in a clinical setting, including a video as well as downloadable brochures.